
Ana María Vesga
Ana María Vesga is the President of the Colombian Association of Integrated Medicine Companies (Acemi). In recent news, she emphasized the financial difficulties faced by health promoting companies (EPS) in Colombia, particularly those intervened in 2024, which may be at risk of liquidation due to significant losses and inadequate solutions for the healthcare system.
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
Colombia | 2 | 4.00 | 0.12% | +0% | 50,882,884 | 60,252 | $350,000 | 414$ |
Totals | 2 | 50,882,884 | 60,252 | $350,000 | 414$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Colombia:
Ana María Vesga, presidenta ejecutiva de Acemi, was emphatic in stating that the decree is illegal and that the guild is preparing to sue it in court.
3
Colombia:
Ana María Vesga is the president of Acemi.
5
Colombia:
Ana María Vesga is the president of the EPS Acemi who discussed the urgent need for financial agreements in the health system.
3
Colombia:
Ana María Vesga is the director of Acemi who reacted to the Constitutional Court's decision regarding EPS Sanitas.
8
Colombia:
Ana María Vesga, president of Acemi, explained the proposal for a new methodological approach to ensure true agreements based on data and technical analysis.
8
Colombia:
Ana María Vesga is the president of Acemi, advocating for the inclusion of various stakeholders in the health discussions.
6
Colombia:
Ana María Vesga is the president of Acemi who criticizes the government's lack of technical conversation regarding the health crisis.
4
Colombia:
Ana María Vesga is the president of Acemi who criticized the government's figures regarding the pharmaceutical sector.
4
Colombia:
Ana María Vesga, the executive president of the Colombian Association of Integral Medicine Companies (Acemi), indicated that the EPS intervened in 2024 could be at risk of liquidation.
6